Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Methylphenidate in Children and Adolescents With KBG Syndrome: An N-of-1 Series

NCT06465641 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT06465641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06465641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Methylphenidate in Children and Adolescents With KBG Syndrome: An N-of-1 Series
Lead sponsor
Radboud University Medical Center
Phase
Phase 4
Overall status
Recruiting
Start date
November 13, 2024
Completion date
October 1, 2028
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adhd - combined type, kbg syndrome